Mercado europeo de narcolepsia hasta 2027: análisis regional y pronósticos por tipo (narcolepsia con cataplejía, narcolepsia sin cataplejía y narcolepsia secundaria); Producto (estimulantes del sistema nervioso central (SNC), oxibato de sodio y antidepresivos); Canal de Distribución (Farmacias Hospitalarias y Farmacias Minoristas) y País
Se prevé que el mercado europeo de la narcolepsia alcance los 1.532,5 millones de dólares en 2027 desde los 671,1 millones de dólares de 2018. Se espera que el mercado de la narcolepsia aumente con una tasa compuesta anual del 9,7% entre 2019 y 2027. .
Se estima que el mercado de la narcolepsia crecerá debido a la factores impulsores como el aumento de la investigación y los desarrollos y el aumento de la concienciación en toda la región. Sin embargo, es probable que factores como los desafíos relacionados con la narcolepsia actúen como un factor restrictivo importante para el crecimiento del mercado.
< p>La narcolepsia es un raro trastorno crónico del sueño causado por la pérdida de neuronas que producen hipocretina. Se han realizado varios avances para fabricar medicamentos que puedan reducir los síntomas de la narcolepsia. Se están llevando a cabo varias investigaciones y desarrollos en países como Alemania, el Reino Unido y otros países de la región europea. Por ejemplo, en abril de 2019, en Alemania, se llevaron a cabo actividades de investigación y desarrollo en el Inserm y la Université; de Montpellier. La investigación se llevó a cabo en colaboración con equipos internacionales que ayudaron a realizar estudios de investigación epidemiológica y clínica del medicamento Solriamfetol entre personas que viven con narcolepsia.
Además, el estudio se realizó en colaboración con Jazz Pharmaceuticals, la empresa ha invertido en el ensayo y también posee una licencia para desarrollar y comercializar Solriamfetol. El estudio fue un ensayo clínico de fase III y los resultados mostraron que el fármaco no tiene efectos secundarios para los pacientes que viven con narcolepsia. Por lo tanto, debido a las crecientes actividades de investigación y desarrollo para la narcolepsia, es probable que mejore el crecimiento del mercado durante el período de pronóstico.
span>
Ingresos y pronósticos del mercado de narcolepsia en Alemania hasta 2027 (millones de dólares estadounidenses)
< /span>
Europa Narcolepsia - ndash; Segmentación del mercado
Mercado europeo de la narcolepsia: ndash; Por tipo
Narcolepsia con cataplejía
Narcolepsia sin cataplejía
Narcolepsia secundaria
Mercado europeo: mercado europeo Por producto
Estimulantes del sistema nervioso central (SNC)
Oxibato de sodio
Antidepresivos
Mercado europeo: mercado europeo Por canal de distribución
Farmacias hospitalarias
Farmacias minoristas
Por geografía
Europa
Estados Unidos
Canadá
México
Perfiles de la empresa
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals plc< /span>
Arena Pharmaceuticals, Inc.
Graymark Healthcare, Inc.
Novartis AG
Takeda Pharmaceutical Company Limited
Mylan NV
BIOPROJET
Shionogi & Co., Ltd.
Ligand Pharmaceuticals, Inc
Europe Narcolepsy Strategic Insights
Strategic insights for Europe Narcolepsy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Get more information on this report
Europe Narcolepsy Report Scope
Report Attribute
Details
Market size in 2018
US$ 671.1 Million
Market Size by 2027
US$ 1,532.5 Million
Global CAGR (2019 - 2027)
9.7%
Historical Data
2016-2017
Forecast period
2019-2027
Segments Covered
By Tipo
Narcolepsia con cataplejÃa
Narcolepsia sin cataplejÃa
Narcolepsia secundaria
By Producto
Estimulantes del sistema nervioso central
oxibato de sodio
antidepresivos
By Canal de distribución
farmacias hospitalarias
farmacias minoristas
Regions and Countries Covered
Europa
Reino Unido
Alemania
Francia
Rusia
Italia
resto de Europa
Market leaders and key company profiles
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals plc
Arena Pharmaceuticals, Inc.
Graymark Healthcare, Inc.
Novartis AG
Takeda Pharmaceutical Company Limited
Mylan N.V.
BIOPROJET
Shionogi & Co., Ltd.
Ligand Pharmaceuticals, Inc
Get more information on this report
Europe Narcolepsy Regional Insights
The regional scope of Europe Narcolepsy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
Get more information on this report
Identical Market Reports with other Region/Countries
The Europe Narcolepsy Market is valued at US$ 671.1 Million in 2018, it is projected to reach US$ 1,532.5 Million by 2027.
What is the CAGR for Europe Narcolepsy Market by (2019 - 2027)?
As per our report Europe Narcolepsy Market, the market size is valued at US$ 671.1 Million in 2018, projecting it to reach US$ 1,532.5 Million by 2027. This translates to a CAGR of approximately 9.7% during the forecast period.
What segments are covered in this report?
The Europe Narcolepsy Market report typically cover these key segments-
Tipo (Narcolepsia con cataplejía, Narcolepsia sin cataplejía, Narcolepsia secundaria)
Producto (Estimulantes del sistema nervioso central, oxibato de sodio, antidepresivos)
Canal de distribución (farmacias hospitalarias, farmacias minoristas)
What is the historic period, base year, and forecast period taken for Europe Narcolepsy Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Narcolepsy Market report:
Historic Period : 2016-2017
Base Year : 2018
Forecast Period : 2019-2027
Who are the major players in Europe Narcolepsy Market?
The Europe Narcolepsy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
Teva Pharmaceutical Industries Ltd.
Jazz Pharmaceuticals plc
Arena Pharmaceuticals, Inc.
Graymark Healthcare, Inc.
Novartis AG
Takeda Pharmaceutical Company Limited
Mylan N.V.
BIOPROJET
Shionogi & Co., Ltd.
Ligand Pharmaceuticals, Inc
Who should buy this report?
The Europe Narcolepsy Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Europe Narcolepsy Market value chain can benefit from the information contained in a comprehensive market report.
Personal & transactional information is kept safe from unauthorized use.
WHAT'S INCLUDED IN FULL REPORT : Market Dynamics,
Competitive Analysis and Assessment, Define Business Strategies, Market Outlook and
Trends, Market Size and Share Analysis, Growth Driving Factors, Future Commercial
Potential, Identify Regional Growth Engines